This mechanism is also influencing the pathogenesis of autoimmune lymphoproliferative syndromes due to mutations in Fas or FasL and should be kept in mind for their treatment [115]. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.